Conformal and stereotactic radiotherapy in hepatocellular carcinoma

Annali Italiani di Chirurgia

Volumn 79, Issue 2, 2008, Pages 107-110

  Scorsetti, Marta ^a   Bignardi, Mario ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Conformal radiotherapy; Hepatocellular carcinoma; Stereotactic radiotherapy

Indexed keywords

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSURGERY; STEREOTACTIC PROCEDURE;

CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; HUMANS; LIVER NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; STEREOTAXIC TECHNIQUES;

EID: 54449093240     PISSN: 2239253X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Baisden JM, Sheng K Molloy JA, et al: Helical tomotherapy SBRT for liver metastases: recommendations for potential candidates based on tumor size and location. Int J Radiat Oncol Biol Phys, 2005; 63 (Suppl.1): S286.
2. Ben-Josef E, Lawrence TS: Radiotherapy for Unresectable Hepatic Malignancies. Semin Radiat Oncol, 2005; 15:273-78.
3. Blomgren H, Lax I, NäslundI, et al: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol, 1995; 34:861-870.
4. Boda-Heggemann J, Walter C, Mai S, et al: Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound. Strahlenther Onkol, 2006; 182:216-21.
5. Bush DA, Hillebrand DJ, Slater JM, et al: High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology, 2004; 127:S189-93.
6. Carey Sampson M, Katz A, Constine LS: Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol, 2006; 16:67-76.
7. Cheng JC, Liu HS, Wu JK, et al: Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys; 2005, 62:1150-156.
8. Choi BO, Jang HS, Kang KM, et al: Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol, 2006; 36:154-58.
9. Dawson LA, Normolle D, Baiter JM, et al: Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys, 2002; 53:810-21.
10. Dawson LA, Ten Haken RK.: Partial Volume Tolerance of the Liver to Radiation Semin Radiat Oncol, 2005; 15:279-83.
11. Dvorak P, Georg D, Bogner J, et al: Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Int J Radiat Oncol Biol Phys, 2005; 61:1572-581.
12. Fowler JF, Tome WA, Fenwick JD, et al: A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys; 2004, 60:1241-56.
13. Fowler JF, Tome WA, Welsh JS: Estimation of required doses in stereotactic body radiation therapy. In: Kavanagh BD, Timmerman RD, editor. Stereotactic body radiation therapy. New York: Lippincott Williams & Wilkins; 2005.
14. Fuss M, Salter BJ, Herman TS, et al: External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology; 2004, 127: S206-17.
15. Gannon CJ, Curley SA: The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol, 2005; 15:265-72.
16. Gillams AR: Liver ablation therapy. Br J Radiol, 2004; 77:713-23.
17. Greco C, Catalano G, Di Grazia A, et al: 2004; 90:73-79.
18. Guo WJ, Yu EX: Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. Br J Radiol, 2000; 73:1091-97.
19. Hawkins MA, Dawson LA.: Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer, 2006; 106:1653-663.
20. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II. Trial J Clin Oncol, 2001; 19:164-70.
21. Kelsey CR, Schefter T, Nash SR, et al: Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol; 2005, 28:576-80.
22. Li B, Yu J, Wang L, et al: Study of local three-dimensional conformai radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Am J Clin Oncol, 2003; 26:e92-e99.
23. Lin CS, Jen YM, Chiu SY, et al: Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy. Jpn J Clin Oncol, 2006; 36:212-17.
24. Liu L, Bassano DA, Prasad SC, et al: The linear-quadratic model and fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys, 2003; 57:827-32.
25. Liu MT, Li SH, Chu TC, et al: Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol, 2004; 34:532-39.
26. Liu R, Buatti JM, Howes TL, et al: Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys, 2006, 66:906-12.
27. Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 1999; 19:329-38.
28. Mornex F, Girard N, Merle P, et al: Tolerance and efficacy of conformai radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1phase II trial. Cancer Radiother, 2005, 9:470-76.
29. Park HC, Seong J, Han KH, et al: Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2002, 54:150-55.
30. Potters L, Steinberg M, Rose C, et al: American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 2004, 60:1026-32.
31. Schefter TE, Cardenes HR, Kavanagh BD: Stereotactic body radiation therapy for liver tumors. In: Kavanagh BD, Timmerman RD (eds): Stereotactic body radiation therapy. New York: Lippincott Williams & Wilkins, 2005.
32. Schefter TE, Kavanagh BD, Timmerman RD, et al: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol, Biol Phys; 2005, 62:1371-378.
33. Timmerman RD, Forster KM, Chinsoo Cho L: Extracranial stereotactic radiation delivery. Semin Radiat Oncol, 2005; 15:202-7.
34. Wada H, Takai Y, Nemoto K, Yamada S: Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys, 2004; 58:1114-120.
35. Wulf Hadinger U, Oppitz U, et al: Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol, 2001; 177:645-655.
36. Wulf J, Hadinger U, Oppitz U, et al: Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol, 2003; 66:141-50.
37. Wulf J, Hadinger U, Oppitz U, et al: Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother, Oncol; 2000, 57:225-36.
38. Wurm RE, Gum F, Erbel S, et al: Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol, 2006, 45:881-89.
39. Zeng ZC, Tang ZY, Fan J, et al: A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J, 2004; 10:307-16.